HEALTHCARE BROKERAGE EVENT 2020
Medical Devices in China: Market opportunities, NMPA registration and new post-market surveillance requirements
China continues to rely on high-end medical technology from abroad. According to the annual report on “China Medical Device Registration”, the top five countries registering their products in China are the USA, Germany, Japan, South Korea and Switzerland; And the number of approved registrations in 2019 increased by 53.2% compared to 2018.
Are you a medical device manufacturer interested in the Chinese market but concerned about regulatory hurdles? In this webinar, Cisema analyses and describes the medical market opportunities as China’s insatiable healthcare demands continue to grow. Next, you will receive an overview over regulatory hurdles and on how to register your MedTech products for sale in China with the NMPA (former CFDA). As part of this, the importance of finding the right clinical pathway early on is explained, as well as the choice of NMPA Legal Agent. The webinar will finish with insights into China’s complex regulatory landscape with its increasing focus on the entire product life and post-market surveillance for MedTech in China. This is valuable as the regulatory environment is fast changing.
Anna King
Webinar Host - Cisema
, ,